Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin α in anemic cancer patients receiving platinum-based chemot

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1289-1296

  Granetto, Cristina ^a   Ricci, Sergio ^b   Martoni, Andrea ^c   Pezzella, Giuseppe ^d   Testore, Franco ^e   Mattioli, Rodolfo ^a   Lampignano, Maria ^f   Tacconi, Fiorenzo ^g   Porrozzi, Stella ^h   Gasparini, Giampietro ⁱ   Mantovani, Giovanni ^j  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b Azienda Ospedaliera Universitaria Santa Chiara   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SS Annunziata Hospital   (Italy)

^e Ospedale Civile di Asti   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g MAGGIORE HOSPITAL   (Italy)

^h Hand Surgery Unit   (Italy)

ⁱ BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^j UNIVERSITY OF CAGLIARI   (Italy)

more..

Author keywords

Anemia; Cancer; Epoetin

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; PLATINUM; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BIOSYNTHESIS; BLOOD TRANSFUSION; BODY WEIGHT; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAFETY; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; BODY WEIGHT; EPOETIN ALFA; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PLATINUM; QUALITY OF LIFE; RANDOM ALLOCATION; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 2142858255     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Abels RI: Recombinant human erythropoietin in the treatment of anaemia of cancer. Acta Haematol 87: 4-11, 1992.
2. Littlewood TJ, Bajetta E, Nortier JW, et al: Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19: 2865-2874, 2001. (Pubitemid 32538196)
3. Glaspy J, Bukowski R, Steinberg D, et al: Impact of therapy with epoetin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol 15: 1218-1234, 1997. (Pubitemid 27106310)
4. Demetri GD, Kris M, Wade J, et al: Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 16: 3412-3425, 1998. (Pubitemid 28481641)
5. Gabrilove JL, Cleeland CS, Livingston RB, et al: Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19: 2875-2882, 2001. (Pubitemid 32538197)
6. Ludwig H and Fritz E: Anemia of cancer patients: patient selection and patient stratification for epoetin treatment. Semin Oncol 25: 35-38, 1998. (Pubitemid 28326222)
7. Vogelzang NJ, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. Semin Hematol 34: 4-12, 1997. (Pubitemid 27319139)
8. Curt GA, Breitbart W, Cella D, et al: Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5: 353-360, 2000.
9. Groopman JE and Itri LM: Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 91: 1616-1634, 1999. (Pubitemid 29479929)
10. Caro JJ, Salas M, Ward A, et al: Anemia as an independent prognostic factor for survival in patients with cancer. Cancer 91: 2214-2221, 2001. (Pubitemid 32552805)
11. Glaser CM, Millesi W, Kornek G, et al: Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50: 705-715, 2001. (Pubitemid 32519598)